To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

C-reactive Protein Testing Market size was valued at USD 3066.45 million in 2019 and is poised to grow from USD 3118.68 million in 2023 to USD 3568.69 million by 2031, growing at a CAGR of 2.4% in the forecast period (2024-2031).

C-reactive protein testing market is fragmented with the presence of various large international and local market players operating around the globe. The major key players of the market are implanting on several business strategies including mergers, acquisitions, collaborations, new product launches, and rising research & development activities for expanding their market share and product offerings to cater the rising consumer demand from all over the world. 'Thermo Fisher Scientific Inc.', 'Roche Diagnostics', 'Abbott Laboratories', 'Beckman Coulter', 'Bio-Rad Laboratories', 'Siemens Healthcare', 'Quest Diagnostics', 'Ortho Clinical Diagnostics', 'Randox Laboratories', 'Boditech Med Inc.', 'Merck Millipore', 'BioMerieux', 'Trinity Biotech', 'Alere Inc.', 'Becton, Dickinson and Company (BD)', 'Sekisui Diagnostics', 'Tosoh Bioscience Inc.', 'DiaSorin S.p.A.', 'Fujifilm Corporation', 'Abaxis, Inc.'

Increasing number of cardiovascular diseases coupled with the rising research and development activities for enhancing C-reactive protein testing methods are the key factors expected to drive the growth of the C-reactive protein testing market over the forecast period. According to our findings, cardiovascular diseases results in over 800,000 deaths in the United States, and around 2,200 patients have died due to cardiovascular disorder.

In the recent years, the number of government initiatives has increased to grow awareness towards prevention and treatment of various types of chronic disorders, which is fueling the demand for the market at a strong growth rate. Due to this, CRP testing has been increasingly incorporated in daily routine clinical practice especially in developed regions such as United States, Germany, France, and Japan, that is likely to have a positive impact on the market growth over the coming years.

Globally, North America region dominated the C-reactive protein testing market with a holding of healthy market share in 2021. Early adoption of advanced technology, rising adoption of innovative devices, and continuously rising focus on clinical research are the major factors projected to drive the growth of the market in the region over the coming years. In addition, rising prevalence of cancer disease in the United States has resulted in wider use of CRP tests across the region. For instance, according to the American Cancer Society, prostate cancer emerged as the second most diagnosed cancer and third major cause of deaths in men in the United States.

Feedback From Our Clients

Global C-reactive Protein Testing Market

Product ID: SQMIG35A2715

$5,300
BUY NOW